Arcturus Therapeutics Ltd Stock Nasdaq
Equities
IL0011280240
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 147M | Sales 2025 * | 241M | Capitalization | 726M |
---|---|---|---|---|---|
Net income 2024 * | -68M | Net income 2025 * | 3M | EV / Sales 2024 * | 2.46 x |
Net cash position 2024 * | 364M | Net cash position 2025 * | - | EV / Sales 2025 * | 3.01 x |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-156
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.25% |
Latest transcript on Arcturus Therapeutics Ltd
Managers | Title | Age | Since |
---|---|---|---|
Joseph Payne
CEO | Chief Executive Officer | 52 | 13-02-28 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 19-08-31 |
Chief Operating Officer | 45 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward W. Holmes
BRD | Director/Board Member | 83 | 19-08-31 |
James F. Barlow
BRD | Director/Board Member | 65 | 18-05-26 |
Peter Farrell
CHM | Chairman | 81 | 18-05-26 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+9.45% | 41.68B | |
+45.83% | 41.25B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+1.28% | 12.29B | |
+29.70% | 12.29B | |
+7.78% | 11.15B |